Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.
By the end of the session participants should be able to:
• Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly
• Recognize the need for improving vaccination coverage rates for both the flu and COVID-19.
• Discuss pharmacists’ contribution to flu vaccination strategies.
-Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation- Sweden
-Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention - Switzerland
-Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations-France
-Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies-Portugal